St. Johns Investment Management Company LLC Has $737,000 Stake in Metlife Inc (MET)

St. Johns Investment Management Company LLC lessened its stake in shares of Metlife Inc (NYSE:MET) by 10.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 14,577 shares of the financial services provider’s stock after selling 1,651 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in Metlife were worth $737,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Farmers National Bank purchased a new stake in Metlife in the second quarter worth $118,000. Ffcm LLC lifted its stake in Metlife by 2,020.8% in the third quarter. Ffcm LLC now owns 2,248 shares of the financial services provider’s stock worth $119,000 after acquiring an additional 2,142 shares during the period. Cable Hill Partners LLC lifted its stake in Metlife by 246.6% in the third quarter. Cable Hill Partners LLC now owns 2,412 shares of the financial services provider’s stock worth $125,000 after acquiring an additional 1,716 shares during the period. Valeo Financial Advisors LLC purchased a new stake in Metlife in the third quarter worth $151,000. Finally, Fieldpoint Private Securities LLC purchased a new stake in Metlife in the third quarter worth $175,000. 76.27% of the stock is owned by hedge funds and other institutional investors.

In other news, insider Christopher G. Townsend sold 55,712 shares of the firm’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the transaction, the insider now directly owns 25,181 shares in the company, valued at $1,367,076.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Christopher G. Townsend sold 82,731 shares of the firm’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the transaction, the insider now owns 49,660 shares of the company’s stock, valued at $2,711,436. The disclosure for this sale can be found here. 0.32% of the stock is owned by company insiders.

Metlife Inc (NYSE:MET) traded down $1.48 on Tuesday, reaching $51.85. The company’s stock had a trading volume of 9,146,916 shares, compared to its average volume of 4,760,000. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market capitalization of $54,560.00, a P/E ratio of 112.72, a price-to-earnings-growth ratio of 1.20 and a beta of 1.49. Metlife Inc has a twelve month low of $44.43 and a twelve month high of $55.91.

Metlife (NYSE:MET) last posted its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.19. The business had revenue of $16.10 billion during the quarter, compared to the consensus estimate of $15.47 billion. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.28 earnings per share. sell-side analysts predict that Metlife Inc will post 4.4 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Monday, February 5th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 annualized dividend and a dividend yield of 3.09%. Metlife’s payout ratio is presently 347.83%.

A number of brokerages recently commented on MET. Goldman Sachs Group began coverage on Metlife in a research note on Wednesday, October 18th. They issued a “conviction-buy” rating and a $61.00 price target for the company. B. Riley reaffirmed a “neutral” rating on shares of Metlife in a research note on Monday, November 6th. Wells Fargo & Co reaffirmed a “buy” rating on shares of Metlife in a research note on Wednesday, October 18th. ValuEngine lowered Metlife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. Finally, Zacks Investment Research raised Metlife from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a research note on Thursday, November 9th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Metlife presently has a consensus rating of “Hold” and an average price target of $57.90.

WARNING: “St. Johns Investment Management Company LLC Has $737,000 Stake in Metlife Inc (MET)” was originally published by Transcript Daily and is the property of of Transcript Daily. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://transcriptdaily.com/2018/01/17/st-johns-investment-management-company-llc-has-737000-stake-in-metlife-inc-met.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply